Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15822 articles
Screening for Prostate Cancer Starting at Age 50-54 Years. A Population-based Cohort Study.
PSA screening for prostate cancer can decrease prostate cancer mortality among men aged 50-54.
»
10/09/15
Improved outcomes due to changes in organization of care for patients with ovarian cancer in the Netherlands.
Change centralization and treatment sequence have led to improvement in surgical outcome and survival for patients with EOC..
»
11/30/15
Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma.
Among patients with advanced melanoma, pembrolizumab administration was associated with an overall objective response rate of 33%.
»
04/20/16
Circulating MicroRNA-21 Is Involved in Lymph Node Metastasis in Cervical Cancer by Targeting RASA1.
Ras-induced epithelial-mesenchymal transition contributes to miR-21/RASA1 axis promoting cervical cancer cell migration.
»
04/22/16
Lymphovascular invasion of tumor cells in lymph node metastases has a negative impact on survival in esophageal cancer.
LVI in lymph node metastases as an independent prognostic factor for disease-free survival.
»
09/28/15
Invasion and increased expression of S100A4 and CYR61 in mesenchymal transformed breast cancer cells is downregulated by GnRH.
Both S100A4 and CYR61 were found highly expressed in biopsy specimens of breast hyperplasia and malignant breast cancers.
»
02/09/16
High Doses of Antimetabolites Followed by High-Dose Sequential Chemoimmunotherapy and Autologous Stem-Cell Transplantation in Patients With Systemic B-Cell Lymphoma and Secondary CNS Involvement: Final Results of a Multicenter Phase II Trial.
Combination of high doses of antimetabolites, R-HDS, and ASCT is feasible and effective in patients age 18 to 70 years old.
»
08/17/15
Association of AKR1C3 Polymorphisms with Bladder Cancer.
The homozygous variant genotype of rs12529 was found to be inversely associated with UBC.
»
01/26/16
CACUL1 functions as a negative regulator of androgen receptor in prostate cancer cells.
CACUL1 impairs LSD1-mediated activation of AR.
»
02/05/16
Parthenolide induces apoptosis and autophagy through the suppression of PI3K/Akt signaling pathway in cervical cancer.
Parthenolide induces generation of reactive oxygen species.
»
12/19/15
< Prev
Next >